Table 1.
2015–2016 | 2013–2014 | 2011–2012 | |
---|---|---|---|
N (%) | N (%) | N (%) | |
University Affiliated Hospitals | 14 (100 %) | 14 (100 %) | 17 (89 %) |
Lab Infrastructure | |||
Centers: Implants done in OR | 4 (29 %) | 6 (43 %) | 8 (47 %) |
Ablation rooms | 1.9 (1–4)a | 1.8 (1–3)a | 1.6 (1–3)a |
Days/Week Room used for Ablationc | 7.0 (2–14)a | 7.1 (2–14)a | 5.3 (1–13)a |
Implant Days/Weekc | 3.4 (0–5)a | 3.2 (0–5)a | 3.25 (1–6)a |
EP Procedures Performed | |||
Diagnostic EP Procedures | 14 (100 %) | 14 (100 %) | 19 (100 %) |
RF | 14 (100 %) | 13 (93 %) | 19 (100 %) |
Contact Force | 14 (100 %) | n/a | n/a |
Cryoablation point-by-point | 12 (86 %) | 9 (64 %) | n/a |
Cryoballoon | 10 (71 %) | 6 (43 %) | 15 (83 %) |
PVAC | 3 (21 %) | 4 (29 %) | n/a |
NMARQ (circular RF) | 2 (14 %) | 0 | n/a |
Mapping Systems | |||
CARTO | 12 (86 %) | 13 (93 %) | 14 (78 %) |
Intracardiac echo | 12 (86 %) | 12 (86 %) | 14 (78 %) |
EnSite-NavX Velocity | 10 (71 %) | 13 (93 %) | 15 (83 %) |
EnSite-NavX Precision | 8 (57 %) | n/a | n/a |
Mediguide | 2 (14 %) | 2 (14 %) | n/a |
Rhythmia™ | 1 (7 %) | 0 | n/a |
LocaLisa | 1 (7 %) | 1 (7 %) | 1 (6 %) |
STXS | 2 (14 %) | 1 (7 %) | 2 (11 %) |
Imaging Systemsb | |||
General Electric | 1 (7 %) | 1 (7 %) | n/a |
Philips | 8 (57 %) | 8 (57 %) | n/a |
Siemens | 6 (43 %) | 7 (50 %) | n/a |
Toshiba | 2 (14 %) | 2 (14 %) | n/a |
Portable GE | 1 (7 %) | 1 (7 %) | n/a |
a = range
b = present in number of centres
c = days per week room used for ablation x number of rooms